Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued on Tuesday. The brokerage set a “sell” rating on the stock.

Streamline Health Solutions Stock Down 5.2 %

Shares of NASDAQ:STRM opened at $3.10 on Tuesday. The stock has a market cap of $13.25 million, a price-to-earnings ratio of -1.29 and a beta of 1.77. The company has a quick ratio of 0.46, a current ratio of 0.46 and a debt-to-equity ratio of 0.72. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75. The business’s 50 day moving average is $3.62 and its 200 day moving average is $3.42.

Streamline Health Solutions (NASDAQ:STRM) last announced its earnings results on Monday, December 16th. The company reported ($0.61) earnings per share (EPS) for the quarter. Streamline Health Solutions had a negative net margin of 50.51% and a negative return on equity of 56.96%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.